150 related articles for article (PubMed ID: 15631649)
1. [Coagulation factor VII levels in uremic patients and theirs influence factors].
Fang J; Xia LH; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
[TBL] [Abstract][Full Text] [Related]
2. Marked increase of activated factor VII in uremic patients.
Kario K; Matsuo T; Matsuo M; Koide M; Yamada T; Nakamura S; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 May; 73(5):763-7. PubMed ID: 7482400
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
[TBL] [Abstract][Full Text] [Related]
4. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
5. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
6. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
[TBL] [Abstract][Full Text] [Related]
7. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
[TBL] [Abstract][Full Text] [Related]
8. [Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease].
Kario K; Matsuo T; Miyata T
Rinsho Byori; 1995 Dec; 43(12):1201-8. PubMed ID: 8569029
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
[TBL] [Abstract][Full Text] [Related]
10. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
11. Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Hu Y; Xu D; Sun C; Chu Z; Zhen J; Wang H; Wei W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):657-60. PubMed ID: 17357481
[TBL] [Abstract][Full Text] [Related]
12. Coagulation activation in extracorporeal hemodialysis.
Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
[TBL] [Abstract][Full Text] [Related]
13. Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients.
Porreca E; Di Febbo C; di Castelnuovo A; Baccante G; Amore C; Angelini A; Di Nisio M; Donati M; Cuccurullo F; Iacoviello L
Atherosclerosis; 2002 Nov; 165(1):159-66. PubMed ID: 12208482
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. [Factor VII detection and its association with lipid in ischaemic heart disease].
Hu Y; Xu DM; Sun CY; Zhen JE; Wang HF; Wei WN
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):418-20. PubMed ID: 16008850
[TBL] [Abstract][Full Text] [Related]
16. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Kario K; Miyata T; Sakata T; Matsuo T; Kato H
Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
[TBL] [Abstract][Full Text] [Related]
17. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Kario K; Matsuo T; Yamada T; Matsuo M
Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
[TBL] [Abstract][Full Text] [Related]
18. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure.
Matsuo T; Koide M; Kario K; Suzuki S; Matsuo M
Haemostasis; 1997; 27(4):163-7. PubMed ID: 9483170
[TBL] [Abstract][Full Text] [Related]
19. Factor VII hyperactivity in chronic dialysis patients.
Kario K; Matsuo T; Yamada T; Nakao K; Shimano C; Matsuo M
Thromb Res; 1992 Jul; 67(1):105-13. PubMed ID: 1332212
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Ekström M; Silveira A; Bennermo M; Eriksson P; Tornvall P
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):473-7. PubMed ID: 17581323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
